CAA - RxDC reporting form

Capital Blue Cross is preparing to submit the 2024 Consolidated Appropriations Act Drug Cost Reporting (CAA RxDC) on behalf of all group customers with medical and/or Rx coverage with Capital in 2024. To complete the submissions for the D1 section, we must gather information from all our groups. It is an option for our ASO customers. If an ASO customer elects to have us complete the D1 requirement on their behalf, then the group or broker must complete the webform. Capital will submit for ASO small business or fully-insured group customers. Capital will also submit on behalf of ASO group customers who opt in by completing and submitting the form below by March 28, 2025. This reporting covers the 2024 calendar year.

If your group was a small business ASO or fully insured group and ASO for any part of 2024, you will need to complete the form multiple times. One for the designation as a small business ASO or fully insured group and one for the designation as an ASO. If you have any questions about this submission, please contact your producer support or Customer Service.

Groups that have contracted separately with a pharmacy benefit manager (PBM) to administer pharmacy benefits should continue to work with that PBM to report pharmacy data required for D3-D8 responses. Groups that already have completed their reporting requirements or are working with another party to fulfill their reporting obligations should continue with their current reporting plans.

Please note that compliance with the RxDC D1 requirements remains the responsibility of ASO groups. Capital's reporting on behalf of groups does not transfer a group's compliance obligations to Capital. Learn more about this requirement.

All fields are required

Reporting for multiple groups

Download the ASO template or ASO Small Business and Fully Insured template, follow the instructions above to add data for the groups you represent, and share the completed file with us using the continue button below. Do not edit column headings when adding your data.

Reporting for a single group

Use the CAA Rx form to submit data for one group at a time.

Submission template

When you are ready to submit your data, use the upload button to attach your file and then provide your electronic signature.
Upload CAA Rx data
By signing below, I acknowledge and affirm that all of the data and information submitted in connection with this form is true and accurate to the best of my knowledge, information and belief. I understand that Capital Blue Cross will not review or confirm the accuracy of such data that it reports to federal authorities in connection with the RxDC requirements on behalf of any group. On behalf of myself and each group and plan sponsor for whom I am submitting data, I agree and acknowledge that by reporting RxDC data on behalf of a group, Capital Blue Cross is not assuming the group’s or plan sponsor’s legal or regulatory obligations with RxDC requirements.
 

Capital Blue Cross is preparing to submit the 2024 Consolidated Appropriations Act Drug Cost Reporting (CAA RxDC) on behalf of all group customers with medical and/or Rx coverage with Capital in 2024. To complete the submissions for the D1 section, we must gather information from all our groups. It is an option for our ASO customers. If an ASO customer elects to have us complete the D1 requirement on their behalf, then the group or broker must complete the webform. Capital will submit for ASO small business or fully-insured group customers. Capital will also submit on behalf of ASO group customers who opt in by completing and submitting the form below by March 28, 2025. This reporting covers the 2024 calendar year.

If your group was a small business ASO or fully insured group and ASO for any part of 2024, you will need to complete the form multiple times. One for the designation as a small business ASO or fully insured group and one for the designation as an ASO. If you have any questions about this submission, please contact your producer support or Customer Service.

Groups that have contracted separately with a pharmacy benefit manager (PBM) to administer pharmacy benefits should continue to work with that PBM to report pharmacy data required for D3-D8 responses. Groups that already have completed their reporting requirements or are working with another party to fulfill their reporting obligations should continue with their current reporting plans.

Please note that compliance with the RxDC D1 requirements remains the responsibility of ASO groups. Capital's reporting on behalf of groups does not transfer a group's compliance obligations to Capital. Learn more about this requirement.

All fields are required
By signing below, I acknowledge and affirm that all of the data and information submitted in connection with this form is true and accurate to the best of my knowledge, information and belief. I understand that Capital Blue Cross will not review or confirm the accuracy of such data that it reports to federal authorities in connection with the RxDC requirements on behalf of any group. On behalf of myself and each group and plan sponsor for whom I am submitting data, I agree and acknowledge that by reporting RxDC data on behalf of a group, Capital Blue Cross is not assuming the group’s or plan sponsor’s legal or regulatory obligations with RxDC requirements.
 

Submitting Application . . .

Please keep this window open until the confirmation page displays.

Thank you for your submission of the Consolidated Appropriations Act Drug Cost Reporting (CAA RxDC).

Please save this confirmation for your records.

We will update our CAA page when we have completed our submission to the Tri-Agencies on or before June 1, 2025.

There was an error during submission.